Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

Author： Olagunju Adeniyi   Owen Andrew   Cressey Tim R  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.13, 2012-10, pp. : 1501-1522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure

By Staud Frantisek   Cerveny Lukas   Ceckova Martina  

Journal of Drug Targeting, Vol. 20, Iss. 9, 2012-11 ,pp. : 736-763

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Opioids for the Treatment of Acute Maternal Pain During Pregnancy and Lactation

By  

Current Drug Metabolism, Vol. 13, Iss. 6, 2012-07 ,pp. : 721-727

Bentham Science Publishers

Access to resources Recommend Favorite

Maternal drug use in early pregnancy and infant cardiovascular defect

By Kallen B.A.J.   Otterblad Olausson P.  

Reproductive Toxicology, Vol. 17, Iss. 3, 2003-05 ,pp. : 255-261

Elsevier

Access to resources Recommend Favorite

Dapsone Therapy for Malaria During Pregnancy: Maternal and Fetal Outcomes

By Brabin B.J.   Eggelte T.A.  

Drug Safety, Vol. 27, Iss. 9, 2004-01 ,pp. : 633-648

Adis International

Access to resources Recommend Favorite

Anticoagulant Therapy During Pregnancy for Maternal and Fetal Acquired and Inherited Thrombophilia

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4562-4571

Bentham Science Publishers

Access to resources Recommend Favorite